Liam Wilson

The American Medical Association (AMA) recently conducted a survey on healthcare organizations’ efforts to eliminate race-based clinical algorithms and decision-making tools that inaccurately use race as a substitute for genetic or biological ancestry. The survey revealed that half of these organizations have already eliminated or are actively working towards eliminating such practices. This development is
0 Comments
In the midst of geopolitical conflicts, some investors are reevaluating their approach to investing. While defense stocks traditionally experience a surge in performance during times of war, a group of everyday investors have chosen to prioritize their moral compass over potential financial gains. These individuals are consciously avoiding defense stocks, opting for investments that align
0 Comments
In today’s digital age, having access to reliable and high-speed internet is no longer a luxury, but a necessity. However, many individuals and businesses still face the challenge of limited connectivity options, especially in areas where fiber broadband is unavailable. Reliance has taken a step forward to address this issue with the introduction of Jio
0 Comments
Like a force of nature, Taylor Swift has the power to not only captivate audiences with her music but also influence industries beyond the realm of entertainment. From hurricanes to blizzards, and now even airlines, the singer’s reach knows no bounds. In a surprising turn of events, an airline recently waived ticket-change fees for customers
0 Comments
The ARIES-HM3 trial has provided new insights into the antithrombotic regimen for patients with HeartMate 3 left ventricular assist devices (LVADs). The trial compared the outcome of dropping aspirin from the treatment regimen after LVAD implantation, and the results suggest that this approach may be safer than the conventional combination therapy. This article critically examines
0 Comments
Novo Nordisk’s groundbreaking drug, Wegovy, has shown tremendous potential in reducing the risk of serious cardiovascular complications in individuals with obesity and heart disease. In the highly anticipated Select study, which included approximately 17,500 participants without diabetes, Wegovy demonstrated a significant impact on heart attacks, signaling a new frontier for the drug. The comprehensive results
0 Comments